News

Harwood Private Equity acquires National Slimming and Cosmetic Clinics

28 September 2018

Harwood Private Equity has acquired National Slimming and Cosmetic Clinics (NSC) with a management buy-in of the UK’s largest group of medicated weight-loss treatment centres.  NSC has 26 clinics across the UK and will be led by chief executive officer Maurice Kelly, who has worked within the Harwood portfolio before and has wide experience of multi-site businesses and the weight-loss sector.

Harwood Private Equity exits Curtis Gilmour and invests in Pelsis

14 August 2018

Harwood Private Equity has achieved a full exit from its 2013 investment in Curtis Gilmour, a prominent US-based manufacturer of specialist pest control equipment, and has invested into the new group created by its merger with Pelsis, a UK company and the leading European distributor of branded pest control products.  Harwood and another UK private equity investor are equity partners in the new enlarged group that will have a consolidated turnover of €125 million with significant potential for growth. 

Harwood Private Equity invests in Tradewise

20 December 2017

Harwood Private Equity has invested in Tradewise, an Enfield-based, market-leading provider of road risk insurance to the UK motor trade sector (dealers and repairers), underwritten through a partner company in Gibraltar.  Tradewise also offers cover within other niche commercial and non-standard vehicle insurance categories in the UK and certain European countries.  James Humphreys is CEO and will continue to lead the company.

Harwood Private Equity exits Essenden

13 April 2017

Harwood Private Equity has achieved an exit from its investment in Essenden through an initial public offering of the Group’s shares on the London Stock Exchange, resulting in a successful outcome for investors. The business has been renamed Ten Entertainment Group plc.

Ten Entertainment Group is a leading operator of indoor bowling and family entertainment centres in the UK, operating under the Tenpin brand.

Harwood Private Equity acquired the company in 2015 and since then has backed further site acquisitions and organic operational initiatives driving significant sales and profit growth.

Harwood Private Equity invests in Inspecs

9 February 2017

Harwood Private Equity has invested in Inspecs, the Bath-based eyewear design, manufacturing and distribution business.  The company produces spectacles for various brands, both under licence and private label. The investment enabled Inspecs to acquire the highly complementary Killine Group, which offers a wide range of optical products designed in Europe and produced in two proprietary factories in China and Vietnam.  Robin Totterman is the founder and CEO of Inspecs and will continue the lead the company.

Harwood Private Equity acquires Journey Group PLC

15 November 2016

Harwood Private Equity has acquired Journey Group plc through a public to private transaction for £32 million.  Journey Group is a provider of in-flight catering to the airline industry. It services Los Angeles International Airport (LAX) and Memphis International Airport (MEM) under the brand name Airfayre™.  Joe Golio will continue to lead the company as CEO, and Bob Gates, founder of R&R Uniforms, Inc., has been appointed non-executive Chairman.

Harwood Private Equity acquires Source BioScience plc

16 September 2016

Harwood Private Equity and Continental Investment Partners have jointly acquired Source BioScience plc through a public-to-private transaction for £65 million. The company provides laboratory services and products to the healthcare and clinical, life science research and biopharma industries.  Services include diagnostic testing for cancer and other infectious disease, DNA sequencing and contract research activities, cryostorage and stability testing.  Products include serology products for blood and tissue banking, life science research reagents and controlled environment chambers. Source BioScience operates ten facilities across the UK, Ireland, Germany and the US and has customers in over 90 countries.  Dr Nick Ash is the CEO of Source BioScience and will continue the lead the company.

Harwood Private Equity backs Coventbridge Group Ltd

11 March 2016

Coventbridge Group Limited, a new company formed by Harwood Private Equity, has acquired and merged the businesses of ICS Merrill and GlobalOptions making it the largest outsource provider of insurance claims investigative services in North America, in addition to its UK trading operations. Coventbridge is pursuing a buy and build strategy to expand its UK and Continental Europe footprint led by non-executive chairman Roger Day, a former Ace and Zurich executive, and Dave Merrill, formerly CEO of ICS Merrill.

B&G rebrands to “Curtis Gilmour” and expands through acquisition

5 February 2016

Harwood portfolio company B&G, a leading manufacturer of specialist equipment for the control of insects and rodents, has adopted the name Curtis Gilmour and expanded through the acquisition of two new businesses.  Curtis Gilmour  acquired Cardiff based Agrisense Industrial Monitoring Limited, and Silvandersson AB of Sweden.  The new acquisitions expand Curtis Gilmour’s range of pest control solutions through the addition of crawling and flying insect traps, and increase UK and European distribution.

Harwood Private Equity acquires Essenden plc

7 August 2015

Essenden plc has been acquired through a public-to-private transaction for £40 million. Essenden is the second largest operator of indoor bowling and family entertainment centres in the UK, operating under the Tenpin brand. It currently has more than 30 sites offering ten-pin bowling games, bar and restaurant services, amusement and gaming machines and other related leisure activities. Nick Basing, an operational adviser to Harwood Private Equity, is the current Chief Executive Officer of Essenden. Nick will be continuing in the capacity of Executive Chairman of the business.